The medical benefits of mesenchymal stem cells (MSCs), the same type of cells used by Celltex in our proprietary isolation and banking technology, are far-reaching. Researchers in Vadodara, India have conducted a study using MSCs that may be helpful for those using insulin to treat diabetes. Dr. Rajini Vyas and her team began the study in 2006 and focused on MSCs. Through the process of differentiation, Islet-like Cell Aggregates (ICA), which are clusters of cells that produce hormones, are created from MSCs. These ICA cells are later characterized by their ability to produce insulin. As a therapy, these ICAs are injected into the pancreatic area of the abdomen, and may have the ability to replace insulin dependency among those living with type 1 diabetes. Dr. Vyas and team hope that they will be able to provide an alternative to insulin treatment in the next five years. To read the full article click here.
The post City scientists’ stem cell research could be boon for diabetics appeared first on Celltex Therapeutics.